Cargando…
Impfungen unter Ofatumumab gelingen
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183242/ http://dx.doi.org/10.1007/s15016-023-3126-6 |
_version_ | 1785041913166954496 |
---|---|
author | Facharztmagazine, Redaktion |
author_facet | Facharztmagazine, Redaktion |
author_sort | Facharztmagazine, Redaktion |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10183242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-101832422023-05-16 Impfungen unter Ofatumumab gelingen Facharztmagazine, Redaktion NeuroTransmitter Pharmaforum Springer Medizin 2023-05-15 2023 /pmc/articles/PMC10183242/ http://dx.doi.org/10.1007/s15016-023-3126-6 Text en © Berufsverband Deutscher Nervenärzte e.V. (BVDN) 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Pharmaforum Facharztmagazine, Redaktion Impfungen unter Ofatumumab gelingen |
title | Impfungen unter Ofatumumab gelingen |
title_full | Impfungen unter Ofatumumab gelingen |
title_fullStr | Impfungen unter Ofatumumab gelingen |
title_full_unstemmed | Impfungen unter Ofatumumab gelingen |
title_short | Impfungen unter Ofatumumab gelingen |
title_sort | impfungen unter ofatumumab gelingen |
topic | Pharmaforum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183242/ http://dx.doi.org/10.1007/s15016-023-3126-6 |
work_keys_str_mv | AT facharztmagazineredaktion impfungenunterofatumumabgelingen |